Drug-induced porphyrin biosynthesis--XIX. Potentiation of the porphyrin-inducing effects of SKF 525-A in the chick embryo liver by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine, an antihibitor of ferrochelatase.

[1]  K. Anderson.  Effects of antihypertensive drugs on hepatic heme biosynthesis, and evaluation of ferrochelatase inhibitors to simplify testing of drugs for heme pathway induction. , 1978, Biochimica et biophysica acta.

[2]  G. S. Marks,et al.  Drug-induced porphyrin biosynthesis-XI. Effect of SKF 525-A on the activity of porphyrin-inducing drugs in chick embryos, chickens and rats. , 1976, Biochemical pharmacology.

[3]  U. Meyer,et al.  Effect of Lead on Hepatic δ‐Aminolaevulinic Acid Synthetase Activity in the Rat: A Model for Drug Sensitivity in Intermittent Acute Porphyria * , 1976, European journal of clinical investigation.

[4]  S. Granick,et al.  HEME CONTROL ON THE SYNTHESIS OF DELTA‐AMINOLEVULINIC ACID SYNTHETASE IN CULTURED CHICK EMBRYO LIVER CELLS * , 1975, Annals of the New York Academy of Sciences.

[5]  B. Brodie,et al.  Concepts in Biochemical Pharmacology , 1975, Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology.

[6]  M. W. Roomi,et al.  Drug-induced porphyrin biosynthesis. 8. Investigation of the importance of an allyl group for activity in substituted acetamides. , 1973, Canadian journal of physiology and pharmacology.

[7]  A. Kappas,et al.  Drug stimulation of -aminolevulinic acid synthetase and cytochrome P-450 in vivo in chick embryo liver. , 1973, The Journal of pharmacology and experimental therapeutics.

[8]  G. Abbritti,et al.  Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice. , 1973, The Biochemical journal.

[9]  F. DeMatteis.  Drug interactions in experimental hepatic porphyria. A model for the exacerbation by drugs of human variegate porphyria. , 1973 .

[10]  G. S. Marks,et al.  Drug-induced porphyrin biosynthesis. VI. Uptake and biotransformation of DDC and an inactive analogue. , 1972, Biochemical pharmacology.

[11]  T. Tephly,et al.  Effect of drugs on heme synthesis in the liver. , 1971, Metabolism: clinical and experimental.

[12]  R. J. Porra,et al.  Studies on ferrochelatase. The effects of thiols and other factors on the determination of activity. , 1967, The Biochemical journal.

[13]  G. S. Marks,et al.  Studies of the relationship between chemical structure and porphyria-inducing activity. , 1965, Biochemical pharmacology.

[14]  D. Rall,et al.  TOXICOLOGY AND THE BIOMEDICAL SCIENCES. , 1965, Science.

[15]  Kenneth M. Snader,et al.  The Hantzsch Reaction. I. Oxidative Dealkylation of Certain Dihydropyridines , 1965 .

[16]  R. J. Porra,et al.  Studies on ferrochelatase. 1. Assay and properties of ferrochelatase from a pig-liver mitochondrial extract. , 1963, The Biochemical journal.

[17]  R. Labbé,et al.  Effects of diethyl-1, 4-dihydro-2, 4,6-trimethylpyridine-3,5-dicarboxylate on the metabolism of porphyrins and iron. , 1963, The Journal of biological chemistry.

[18]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.